MTOR and cancer: Rapamycin, different from other therapeutic agents, has been proven to induce autophagy via mTOR inhibition in cancer cells; nevertheless, it also has been considered as an immunosuppressive drug because of its ability to impair DC maturation and T cell proliferation.